Protagonist Therapeutics: 2Q Earnings Snapshot
NEWARK, Calif. (AP) _ Protagonist Therapeutics Inc. (PTGX) on Wednesday reported a loss of $29.2 million in its second quarter.
The Newark, California-based company said it had a loss of $1.18 per share.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 27 cents per share.
Protagonist Therapeutics shares have climbed 44% since the beginning of the year. The stock has dropped 13% in the last 12 months.